Statistical design of Phase II/III clinical trials for testing therapeutic interventions in COVID-19 patients

Because of unknown features of the COVID-19 and the complexity of the population affected, standard clinical trial designs on treatments may not be optimal in such patients. We propose two independent clinical...

Source: BMC Medical Research Methodology - August 31, 2020 Category: Research Authors: Shesh N. Rai, Chen Qian, Jianmin Pan, Anand Seth, Deo Kumar Srivastava and Aruni Bhatnagar Tags: Research article Source Type: research